Neurodevelopmental Outcomes of Preterm Infants Treated for Pain Management With Repeated Doses of Sucrose 24%

• Status: Unknown status
• Trial end date: 2015-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the effect of sucrose 24% for pain prevention on preterm infants. Our hypothesis is that repeated doses of sucrose 24%, given prior to painful procedure,do not impair neurodevelopmental outcomes of preterm infants

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Sheba Medical Center

Criteria

Inclusion Criteria:

• preterm infants born at SMC

Exclusion Criteria:

• need for intubation

• surgery

• need for sedation

• abnormal head ultrasound

• genetic abnormalities

• necrotizing enterocolitis

• other painful conditions other than routine blood exams